Ronald A. Otten - Concepedia

Author

Ronald A. Otten

Centers for Disease Control and Prevention

Also Known As

Monsour, Michael, R A Otten, R. Otten, R.A. Otten, Ronald A Otten, Ronald A. Otten, Ronald Otten, Ronald A. Otten

Publications

515

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention University of Toledo Medical Center National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention National Center for Infectious Diseases Emory University

About

Ronald A. Otten is an author at Centers for Disease Control and Prevention specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	207
2	Immunology	7	7	207
3	Epidemiology	2	2	95
4	Biochemistry	1	1	12
5	Cell Biology	1	1	22

Ronald A. Otten

Publications

481

Citations

H-Index

Page 1

	Year	Citations
Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges Shambavi Subbarao, Ronald A. Otten, Artur Ramos, The Journal of Infectious Diseases	2006	192
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges Dennis Ellenberger, Ronald A. Otten, Bin Li, Virology VaccinationMucosal VaccinationMedicineHuman RetrovirusImmunology	2006	48
Dual Infection with Human Immunodeficiency Virus Type 1 and Type 2: Impact on HIV Type 1 Viral Load and Immune Activation Markers in HIV-Seropositive Female Sex Workers in Abidjan, Ivory Coast John N. Nkengasong, Luc Kestens, Peter D. Ghys, AIDS Research and Human Retroviruses Immune ActivationImmunologyImmunotherapyDual InfectionHuman Retrovirus	2000	47
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci Roberta Raeder, Ronald A. Otten, Linda L. Chamberlin, Journal of Clinical Microbiology Bacterial Immunoglobulin-binding ProteinsGlycobiologyImmunologyBinding ProteinAntigen Processing	1992	38
Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire Stéphania Koblavi‐Dème, Luc Kestens, Debra L. Hanson, AIDS	2004	30
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus Ronald A. Otten, Roberta Raeder, David G. Heath, The Journal of Immunology	1992	25
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs Dennis Ellenberger, Linda S. Wyatt, Bin Li, Virology VaccinationVaccine DevelopmentRhesus MonkeysHuman RetrovirusMulti-protein Hiv-1	2005	25
Immunological applications of type III Fc binding proteins comparison of different sources of protein G Ervin L. Faulmann, Ronald A. Otten, D J Barrett, Journal of Immunological Methods Different SourcesAutoimmune DiseaseType Iii FcMedicineImmunology	1989	22
Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques Ellen N. Kersh, Wei Luo, David R. Adams, Journal of Antimicrobial Chemotherapy	2009	17
Induction of Long-Term Protective Effects against Heterologous Challenge in SIVhu-Infected Macaques François Villinger, William M. Switzer, Bharat Parekh, Virology Sivhu-infected MacaquesViral PersistenceLong-term Protective EffectsImmunologyHeterologous Challenge	2000	15

Page 1